Free press releases distribution network?

Agency / Source: Breeze PR

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



CVRx®, Inc. Introduces New Device Developed to Treat Uncontrollable Hypertension - Federally approved clinical study aims to prove device is a safe and effective way to control high blood pressure - CVRx.com
CVRx®, Inc. Introduces New Device Developed to Treat Uncontrollable Hypertension

 

PRZOOM - /newswire/ - Austin, TX, United States, 2008/04/24 - Federally approved clinical study aims to prove device is a safe and effective way to control high blood pressure - CVRx.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Hypertension affects 73 million Americans and is the leading cause of stroke, heart attack, heart failure and kidney disease according to the American Heart Association. About 25 percent of people with hypertension are unable to control their high blood pressure despite medication, adoption of a healthier lifestyle and other therapies.

To treat this condition, CVRx Inc., a private company, developed a device that stimulates the body’s natural system of lowering blood pressure currently being implanted in select patients across the United States.

Only a limited number of U.S. facilities can perform the surgical procedure involving the device that is currently being studied in an FDA-approved clinical trial.

“We’re very excited that we have the opportunity to offer the advanced technology to people at the end of the road whose doctors have exhausted every option to treat them” said Dr. Robert Feldtman, a cardiovascular surgeon responsible for implanting the device in qualifying Central Texas patients at Scott & White Hospital in Temple.

The device is designed to electrically activate the baroflex, the body’s natural blood pressure regulation system, to watch and control blood pressure. The procedure requires implanting a pulse generator, or battery, and wires under the collarbone, which send signals to the brain suggesting a blood pressure increase. The procedure is similar to a cardiac pacemaker implantation, Dr. Feldtman said.

Investigators at Scott & White Hospital are currently screening patients for participation in the Rheos Pivotal Trial. To qualify, patients must have persistent high blood pressure despite regular treatment with medications.

“Before the implant I took 17 pills a day and since I’ve had the device, I only need one,” said David K., one of 50 patients in the U.S. enrolled in the study. “I’m living proof that it doesn’t have to be that way.”

Sponsored by CVRx Inc., the trial aims to demonstrate that the product, the CVRx Rheos Baroflex Hypertension Therapy System, is a safe and effective treatment for patients to lower uncontrolled high blood pressure.

Clinical studies in Europe have been ongoing for the past four years and results show a significant reduction in implanted patients’ blood pressure according to reports from the European Society of Hypertension in 2007.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Breeze PR

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


CVRx®, Inc. Introduces New Device Developed to Treat Uncontrollable Hypertension

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Mia Vieira - BreezePR.com 
512-236-1911 mia[.]breezemarketingaustin.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Breeze PR securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Breeze PR / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017
MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
Datalogic Announces New Healthcare Memor X3 HC Mobile Computer
Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove
GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  RightITnow Ltd

Visit  S&A Capital Partner Ltd

Visit  NAKIVO, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today